Alliance Wealth Advisors, LLC /UT
Position in NBIX — Neurocrine Biosciences Inc
CIK 1893261
Centerville, UT
Position in NBIX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$221,630
-$58,749 QoQ
Shares Held
1,315
-52.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#589
of 768 holders
Holding Since
Dec 2022
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Alliance Wealth Advisors, LLC /UT holds $454,259 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (48.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRX |
Amneal Pharmaceuticals, Inc.
|
13,439 | $232,629 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,315 | $221,630 |
All Filings in NBIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $221,630 | 1,315 | Shares | Other | 2026-07-23 | |
| 2023-03-31 | $280,379 | 2,770 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $341,598 | 2,860 | Shares | Sole | 2023-02-08 | |
| No filing history on record for this holder in this stock. | ||||||